Who needs 'WikiLeaks' when STOCK Act will do? NIH scientists, other feds sue US
This article was originally published in Scrip
A law enacted in April to prevent members of Congress from engaging in insider trading may actually end up driving some of the top US scientists out of the government, plaintiffs in a new lawsuit filed against the US are charging.
You may also be interested in...
With new funding in hand, Moderna and its infectious disease venture Valera are going full-speed ahead with a Zika vaccine, taking an mRNA approach, which they said could be a more rapid strategy to try to stop the disease.
Allergan CEO Brent Saunders vows not to engage in price gouging and says his firm will limit cost increases to single-digit percentages, occurring only once per year. But it's unclear whether Saunders will stand as a lone wolf in the industry or if others will make similar pledges.
Hillary Clinton's plan to rein in high prices of older medicines, which includes creating a federal panel that has authority to impose fines, may grab headlines, but some analysts think it's unlikely to get very far in a divided Washington.